Atai Beckley N.V. (ATAI)

Insider Trading Filed: 2026-04-22

Chief Medical Officer Craig Kevin James exercised 42,579 stock options at $5.00 per share on 04/20/2026, generating approximately $212,895 in proceeds, followed by an immediate sale indicating profit-taking rather than confidence-building accumulation.
The insider executed transactions under a Rule 10b5-1 trading plan adopted on 12/19/2025, suggesting pre-planned, methodical liquidation rather than opportunistic buying, which is typically a bearish signal for insiders with material information.
James acquired 27,280 shares at $1.50 and 15,299 shares at $1.84 through option exercises, but the same-day sale of 42,579 shares at $5.00 demonstrates net selling pressure with zero net accumulation of common stock by this senior executive.
Following the reported transactions, James maintains 706,859 and 372,701 stock options respectively with expiration dates in 2034-2035, but his direct common stock ownership decreased significantly, indicating reduced confidence in near-term stock performance.

Insider Trading Filed: 2026-04-10

Insider Christian Angermayer and Apeiron Investment Group Ltd. are exercising a significant number of stock options, suggesting confidence in the company's future performance.
Angermayer's direct and indirect ownership of nearly 55 million shares (over 10% of the company) indicates a large stake in Atai Beckley's success.
The vesting schedule of the stock options, with a mix of fully vested and time-based vesting, provides insight into the company's long-term incentive structure for executives.

Important Information